[HTML][HTML] Wnt and GSK3 signaling pathways in bipolar disorder: clinical and therapeutic implications

A Muneer - Clinical Psychopharmacology and Neuroscience, 2017 - ncbi.nlm.nih.gov
The neurobiology of bipolar disorder, a chronic and systemic ailment is not completely
understood. The bipolar phenotype manifests in myriad ways, and psychopharmacological …

The Wnt signaling pathway in bipolar disorder

TD Gould, HK Manji - The Neuroscientist, 2002 - journals.sagepub.com
The Wnt signaling pathway is a highly conserved pathway critical for proper embryonic
development. However, recent evidence suggests that this pathway and one of its key …

Glycogen synthase kinase-3β as a putative therapeutic target for bipolar disorder

MP Dandekar, SS Valvassori… - Current drug …, 2018 - ingentaconnect.com
Background: Bipolar disorder (BD) is a debilitating mental ailment characterized by recurrent
episodes of mania and depression. Primary mood-stabilizing drugs like lithium and …

[HTML][HTML] GSK-3 and Wnt signaling in neurogenesis and bipolar disorder

AJ Valvezan, PS Klein - Frontiers in molecular neuroscience, 2012 - frontiersin.org
The canonical Wnt signaling pathway is critical for development of the mammalian central
nervous system and regulates diverse processes throughout adulthood, including adult …

GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder

MK Rowe, C Wiest, DM Chuang - Neuroscience & Biobehavioral Reviews, 2007 - Elsevier
Bipolar disorder is a serious psychiatric condition that has been treated for over 50 years
with lithium. Lithium is a well established glycogen synthase kinase-3 (GSK-3) inhibitor …

The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder

LW Hu, EM Kawamoto, E Brietzke, C Scavone… - Progress in Neuro …, 2011 - Elsevier
The neurobiology of Bipolar Disorder (BD) is not completely understood, although
abnormalities in neuroplasticity and control of apoptosis have been considered as central …

Gsk3 signalling and redox status in bipolar disorder: evidence from lithium efficacy

A Luca, C Calandra, M Luca - Oxidative medicine and cellular …, 2016 - Wiley Online Library
Objective. To discuss the link between glycogen synthase kinase‐3 (GSK3) and the main
biological alterations demonstrated in bipolar disorder (BD), with special attention to the …

Therapeutic mechanisms of lithium in bipolar disorder: recent advances and current understanding

GS Malhi, T Outhred - CNS drugs, 2016 - Springer
Lithium is the most effective and well established treatment for bipolar disorder, and it has a
broad array of effects within cellular pathways. However, the specific processes through …

Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway

TD Gould, ER Dow, KC O'Donnell… - CNS & Neurological …, 2007 - ingentaconnect.com
Regulation of complex signaling pathways plays a critical role in higher-order brain
functions including the regulation of mood, cognition, appetite, sexual arousal, sleep …

Glycogen synthase kinase-3: a target for novel bipolar disorder treatments

TD Gould, CA Zarate, HK Manji - Journal of Clinical Psychiatry, 2004 - psychiatrist.com
The enzyme glycogen synthase kinase-3 (GSK-3) is a direct target of lithium. While originally
recognized as an important molecule in a limited number of cellular processes, with unclear …